Austrian economists believed the money printing that occurred during the Great Recession of 2008 would engender massive inflation. That indeed turned out to be the case;...
Never before in 25 years, beyond a sharp decline in growth, the World Bank predicted a violent shock for the Sub-Saharan region and its governments. According...
Customers of the German bank should soon be able to enjoy the higher interest rates of foreign banks in private asset management too. Interestingly enough, a...
Avigan is an antiviral drug offered by Toyama Chemical. This Japanese laboratory had been bought by the giant Fujifilm as part of its diversification in health...
The $10 billion financial package is part of the AfDB's response to the pandemic. It will be granted to both governments and the private sector. While...
Investment crowdfunding, also known as collaborative investment, might be the solution for companies in Brazil struggling to cope with the corona crisis. CrowdInvest and ABFintechs presented...
The “policymakers” aren’t going to allow Mr Bear to go about his duties of cleaning up the mess currently residing in most balance sheets around the...
The world is facing unimaginable challenges in relation to the new coronavirus, which is rapidly spreading and generating instability in the area of health and the...
Is the COVID-19 the “black swan” that has unleashed what may become the biggest financial disaster in history? As plagues go it is still small. But...
The biopharmaceutical company Theranexus has just completed the Phase 2 trial of its THN102 drug candidate in Parkinson's disease. The study demonstrated the efficacy of THN102...